Combined Metabolic Activators Therapy Ameliorates Liver Fat in Nonalcoholic Fatty Liver Disease Patients Clinical, Liver HealthANAD StaffOctober 25, 2021
NAD+-Boosting Therapy Alleviates Nonalcoholic Fatty Liver Disease via Stimulating a Novel Exerkine Fndc5/Irisin Clinical, Liver HealthANAD StaffFebruary 25, 2021
The Acute Effect of Metabolic Cofactor Supplementation: A Potential Therapeutic Strategy Against Non-Alcoholic Fatty Liver Disease Clinical, Liver HealthANAD StaffApril 27, 2020
A Randomized Placebo-Controlled Clinical Trial of Nicotinamide Riboside in Obese Men: Safety, Insulin-Sensitivity, and Lipid-Mobilizing Effects Clinical, Pharmacokinetic/Safety, Liver Health, Metabolic HealthANAD StaffJuly 10, 2018
